4.62
-0.15 (-3.14%)
Penutupan Terdahulu | 4.77 |
Buka | 4.68 |
Jumlah Dagangan | 121,720 |
Purata Dagangan (3B) | 317,667 |
Modal Pasaran | 195,354,384 |
Harga / Buku (P/B) | 12.05 |
Julat 52 Minggu | |
Tarikh Pendapatan | 12 Feb 2025 - 17 Feb 2025 |
EPS Cair (TTM) | -0.960 |
Jumlah Hutang/Ekuiti (D/E MRQ) | 1.67% |
Nisbah Semasa (MRQ) | 3.00 |
Aliran Tunai Operasi (OCF TTM) | -15.63 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -15.19 M |
Pulangan Atas Aset (ROA TTM) | -90.68% |
Pulangan Atas Ekuiti (ROE TTM) | -332.67% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Bercampur | Menurun |
Biotechnology (Global) | Bercampur | Menurun | |
Stok | TuHURA Biosciences, Inc. | Menurun | - |
AISkor Stockmoo
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -4.0 |
Purata | -1.00 |
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma. |
|
Sektor | Healthcare |
Industri | Biotechnology |
% Dimiliki oleh Orang Dalam | 41.96% |
% Dimiliki oleh Institusi | 8.43% |
Julat 52 Minggu | ||
Median | 12.00 (159.74%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
HC Wainwright & Co. | 16 May 2025 | 12.00 (159.74%) | Beli | 3.92 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |